ROYAL BANK OF CANADA - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 32 filers reported holding ACER THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
376
-44.9%
0.00%
Q2 2023$1,000682
+5146.2%
0.00%
Q3 2022$013
-87.0%
0.00%
Q2 2021$01000.0%0.00%
Q1 2021$0
-100.0%
100
-95.0%
0.00%
Q3 2020$6,000
-33.3%
2,001
-24.8%
0.00%
Q2 2020$9,000
+350.0%
2,660
+154.5%
0.00%
Q1 2020$2,000
+100.0%
1,045
+277.3%
0.00%
Q4 2019$1,000277
+855.2%
0.00%
Q3 2019$029
-68.5%
0.00%
Q2 2019$0
-100.0%
92
-92.9%
0.00%
Q1 2019$31,0001,296
+25820.0%
0.00%
Q3 2018$050.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Nantahala Capital Management 1,226,191$3,077,7390.20%
Knott David M Jr 140,000$3510.13%
Anson Funds Management LP 129,795$325,7850.05%
Meridian Wealth Management, LLC 71,750$180,0930.02%
Anson Funds Management LP 38,100$95,6310.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 19,000$480.01%
Virtu Financial LLC 10,557$260.00%
TWO SIGMA SECURITIES, LLC 19,747$49,5650.00%
UBS Group AG 1,393$3,4970.00%
SVB WEALTH LLC 11,500$28,8650.00%
View complete list of ACER THERAPEUTICS INC shareholders